Position in EXEL
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$485,848,055
+$119,471,553 QoQ
Shares Held
8,929,389
+4.5% QoQ
Ownership
3.60%
of shares outstanding
% of Portfolio
1.33%
of 13F equity value
Holder Rank
#8
of 751 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FULLER & THALER ASSET MANAGEMENT, INC. holds $1,207,612,518 across 7 Biotechnology names. EXEL ranks #1 (40.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
This page
|
8,929,389 | $485,848,055 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,638,544 | $394,839,947 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
1,491,004 | $116,700,883 | |
| 4 | PTCT |
Ptc Therapeutics, Inc.
|
1,156,819 | $94,361,725 | |
| 5 | CORT |
Corcept Therapeutics Inc
|
710,106 | $61,743,716 | |
| 6 | CELC |
Celcuity Inc.
|
514,396 | $53,816,109 | |
| 7 | VNDA |
Vanda Pharmaceuticals Inc.
|
49,360 | $302,083 |
All Filings in EXEL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $485,848,055 | 8,929,389 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $366,376,502 | 8,542,236 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $348,926,071 | 7,960,896 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $343,648,792 | 8,320,794 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $386,827,213 | 8,775,572 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $287,794,132 | 7,795,074 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $254,110,302 | 7,630,940 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $179,642,196 | 6,922,628 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $49,926,340 | 2,221,911 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $63,082,574 | 2,658,347 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $62,741,047 | 2,615,300 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $55,968,490 | 2,561,487 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $49,189,713 | 2,574,030 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $48,935,249 | 2,521,136 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $39,610,763 | 2,469,499 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $39,452,212 | 2,516,085 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $55,128,965 | 2,647,885 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $60,802,821 | 2,682,083 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $52,897,896 | 2,893,758 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $57,755,854 | 2,732,065 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $3,430,224 | 188,267 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $5,442,631 | 240,931 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $3,940,443 | 196,335 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $4,427,577 | 181,087 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $4,014,315 | 169,095 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $767,874 | 44,592 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||